0Suppliers
1Customers
0Debt Items
4Related Chains

Source-Backed Evidence Depth

Innate Pharma SA (IPHYF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

1Total relationships
0Distinct source URLs
0High confidence
0.720Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Innate Pharma SA Suppliers

No suppliers on recordInnate Pharma SA has not yet been matched to upstream suppliers in our database, or is still being processed.

Innate Pharma SA Customers

TickerNameConfidenceEvidence
SNGX Soligenix, Inc. 72% Reciprocal relationship from SNGX graph: urers of the drug substances is limited. In the event it is necessary or advisable to acquire supplies from alternative suppliers, assuming commercially reaso…

Innate Pharma SA Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Innate Pharma SA.

Innate Pharma SA Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Innate Pharma SA.

Innate Pharma SA Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Innate Pharma SA.

Innate Pharma SA Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNGX Soligenix, Inc. 100.00 1 ['customer']
GRTXD Galera Therapeutics, Inc. 50.00 2
UBC UBC 50.00 2
RODMAN RODMAN 50.00 2
🔐
IPHYF
Unlock IPHYF Supply Chain Data
Verified relationships include:
SNGXSoligenix, Inc.Customer72%
Subscribe — View plans →